Parere positivo del Comitato per i prodotti medicinali per uso umano sul nuovo contraccettivo NOMAC-E2

Health and Fitness Health and Fitness

Thu, March 31, 2011

[ Thu, Mar 31st 2011 ] - Market Wire

MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. sent at 10th Annual Needham Healthcare Conference

[ Thu, Mar 31st 2011 ] - Market Wire

A CIGNA bel©pett a globlis egy©ni eg©szs©gbiz .. zette a CIGNA Globlis Eg©szs©gbiztostsi Opcikat

[ Thu, Mar 31st 2011 ] - Market Wire

PROTOX REPORTS 2010 FINANCIAL RESULTS AND ACHIEVEMENTS

[ Thu, Mar 31st 2011 ] - Market Wire

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

[ Thu, Mar 31st 2011 ] - Market Wire

RXi Pharmaceuticals Aggressively Moves into Late- .. pment with the Agreement to Acquire Apthera, Inc.

[ Thu, Mar 31st 2011 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at the Leerink Swann Cancer Roundtable Conference

[ Thu, Mar 31st 2011 ] - Market Wire

Interim Phase 2 Data Showed Rapid Viral Response .. Telaprevir, Pegylated-Interferon and Ribavirin A

[ Thu, Mar 31st 2011 ] - Market Wire

SuperGen PIM Kinase Presentations at AACR

[ Thu, Mar 31st 2011 ] - Market Wire

SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011

[ Thu, Mar 31st 2011 ] - Market Wire

A.P. Pharma Announces Transfer to OTCQB

[ Thu, Mar 31st 2011 ] - Market Wire

Inhibitex Reports Positive Safety and Antiviral D .. hase 1b Study of HCV Nucleotide Inhibitor INX-189

[ Thu, Mar 31st 2011 ] - Market Wire

Inhibitex Announces Data Presentation at the 46th .. ean Association for the Study of the Liver (EASL)

[ Thu, Mar 31st 2011 ] - Market Wire

The New England Journal of Medicine Publishes Stu .. ational Medicine VICTRELISa" (boceprevir) in Comb

Wed, March 30, 2011

[ Wed, Mar 30th 2011 ] - Market Wire

CIGNA betritt Privatkundensegment mit neuer Krankenversicherung CIGNA Global Health Options

[ Wed, Mar 30th 2011 ] - Market Wire

CIGNA entra nel mercato sanitario globale per le persone lanciando CIGNA Global Health Options

[ Wed, Mar 30th 2011 ] - Market Wire

Antrim Energy Inc. Announces the Filing of Its National Instrument 51-101 Reports

[ Wed, Mar 30th 2011 ] - Market Wire

Baby, It's Cold Outside, But Pharmaceutical Industry Is Hot, an Industrial Info News Alert

[ Wed, Mar 30th 2011 ] - Market Wire

Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.

[ Wed, Mar 30th 2011 ] - Market Wire

Yale and Gilead Sciences Announce Cancer Research Collaboration

[ Wed, Mar 30th 2011 ] - Market Wire

Curis Announces Presentations at 102nd American A .. sociation for Cancer Research Annual Meeting 2011

[ Wed, Mar 30th 2011 ] - Market Wire

Medivation and Astellas Announce Initiation of Ph .. ng MDV3100 With Bicalutamide in Advanced Prostate

[ Wed, Mar 30th 2011 ] - Market Wire

BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials

[ Wed, Mar 30th 2011 ] - Market Wire

Derma Sciences Reports Fourth Quarter Results; Sa .. oducts up 59% over Prior Year; Total Net Sales Ne

[ Wed, Mar 30th 2011 ] - Market Wire

Dr. Reddya?s Announces Completion of the Acquisit .. cillin Facility and Products from GlaxoSmithKline

[ Wed, Mar 30th 2011 ] - Market Wire

Columbia Laboratories' Provides Update on PREGNANT Study Publication

Tue, March 29, 2011

[ Tue, Mar 29th 2011 ] - Market Wire

Somaxon Pharmaceuticals Announces Issuance of Pat .. ting to Pharmacokinetics (Food Effect) of Silenor

[ Tue, Mar 29th 2011 ] - Market Wire

Merc Completes Final Tranche of Private Placement

[ Tue, Mar 29th 2011 ] - Market Wire

ACADIA Pharmaceuticals to Present at the Tenth An .. al Needham Healthcare Conference on April 5, 2011

[ Tue, Mar 29th 2011 ] - Market Wire

Biomagneticsa? Updates on Commercialization of the IOBS Unit

[ Tue, Mar 29th 2011 ] - Market Wire

NuPathe to Present at the 10th Annual Needham Healthcare Conference

[ Tue, Mar 29th 2011 ] - Market Wire

(NYSE Amex: DXR) Daxor Corporation Announces Year End 2010 Earnings

[ Tue, Mar 29th 2011 ] - Market Wire

Curis to Present at the 10th Annual Needham Healthcare Conference

[ Tue, Mar 29th 2011 ] - Market Wire

Derma Sciences Advanced Wound Care Products Featu .. tions at the Diabetic Foot Global Conference 2011

[ Tue, Mar 29th 2011 ] - Market Wire

Phase 3 Study of VX-770 in Children Ages 6 to 11 .. c Fibrosis Showed Profound Improvements in Lung F

[ Tue, Mar 29th 2011 ] - Market Wire

Advisory Contract between Medwell Capital and Spectral Diagnostics Increases

[ Tue, Mar 29th 2011 ] - Market Wire

Medical Facilities Corporation Proposes Conversion to Traditional Common Share Structure

[ Tue, Mar 29th 2011 ] - Market Wire

ZIOPHARM to Present at Upcoming Investor Conferences

Mon, March 28, 2011

[ Mon, Mar 28th 2011 ] - Market Wire

Clinical and Economic Data From The PARTNER Trial to Be Presented at ACC 2011

[ Mon, Mar 28th 2011 ] - Market Wire

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

[ Mon, Mar 28th 2011 ] - Market Wire

Cambridge Hearta?s MTWA Test Featured as Case of .. Week in Diagnostic and Interventional Cardiology

[ Mon, Mar 28th 2011 ] - Market Wire

EnteroMedics Receives CE Mark Certification for t .. g Australian Regulatory Application to Move Forwa

[ Mon, Mar 28th 2011 ] - Market Wire

PacificHealth Laboratories Launches ACCEL RECOVER(R)

[ Mon, Mar 28th 2011 ] - Market Wire

CytRx Announces the Presentation of Bafetinib Stu .. Academy for Cancer Research (AACR) Annual Meeting

[ Mon, Mar 28th 2011 ] - Market Wire

AVI BioPharma Names Peter S. Linsley, Ph.D., Chief Scientific Officer

[ Mon, Mar 28th 2011 ] - Market Wire

Implant Sciences Announces $380,000 in New Contra .. Quantum Sniffer Explosives Trace Detection Device

[ Mon, Mar 28th 2011 ] - Market Wire

Treating Skeletal Muscle Injuries With Pluristem's PLacental eXpanded (PLX) Cells

[ Mon, Mar 28th 2011 ] - Market Wire

Dr. Reddya?s Launches Levocetirizine Tablets in US

[ Mon, Mar 28th 2011 ] - Market Wire

Preclinical Data on AVEO Pharmaceuticalsa? Tivoza .. ipeline to be Presented at AACR 102nd Annual Meet

[ Mon, Mar 28th 2011 ] - Market Wire

A.P. Pharma Announces Fourth Quarter and Full Yea .. 0 Financial Results and Provides Corporate Update

Sun, March 27, 2011

[ Sun, Mar 27th 2011 ] - Market Wire

Helix BioPharma Announces $3.9 Million Private Placement

[ Sun, Mar 27th 2011 ] - Market Wire

Champions Announces Technology Collaboration Util .. Technology Platform for Oncology Drug Developmen

Fri, March 25, 2011

[ Fri, Mar 25th 2011 ] - Market Wire

Edwards Lifesciences to Be Added to the S&P 500 Index

[ Fri, Mar 25th 2011 ] - Market Wire

Neurologix Announces Year End 2010 Results

[ Fri, Mar 25th 2011 ] - Market Wire

Biotonix Announces Results for the 2010 Fourth Quarter and Fiscal Year

[ Fri, Mar 25th 2011 ] - Market Wire

ISOTECHNIKA REPORTS FULL YEAR AND FOURTH QUARTER 2010 FINANCIAL RESULTS

[ Fri, Mar 25th 2011 ] - Market Wire

PacificHealth Laboratories Board Names New Chairman

[ Fri, Mar 25th 2011 ] - Market Wire

Belo Sun Announces Closing of $51.8 Million Equit .. ring Including Exercise in Full of Over-Allotment

[ Fri, Mar 25th 2011 ] - Market Wire

HealthSpring, Inc. Announces Pricing of Public Offering of Common Stock

[ Fri, Mar 25th 2011 ] - Market Wire

Long-Term Safety Data Demonstrated VIMOVOTM Is Ge .. hritis Patients at Risk for NSAID-Associated Gast

[ Fri, Mar 25th 2011 ] - Market Wire

Celsion Corporation Reports Year End 2010 Financial Results and Provides Business Update

[ Fri, Mar 25th 2011 ] - Market Wire

Teleflex Announces Global Distribution Agreement for POLYSITE® Implantable Infusion Ports

Thu, March 24, 2011

[ Thu, Mar 24th 2011 ] - Market Wire

Gilead fija precio de obligaciones senior no garantizadas por valor de $1.000 millones

[ Thu, Mar 24th 2011 ] - Market Wire

CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings

[ Thu, Mar 24th 2011 ] - Market Wire

Baxter International Inc. First Quarter 2011 Financial Results Conference Call

[ Thu, Mar 24th 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2%

[ Thu, Mar 24th 2011 ] - Market Wire

Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck

[ Thu, Mar 24th 2011 ] - Market Wire

Abiomed to Host PROTECT II Investor Meeting at ACC 2011

[ Thu, Mar 24th 2011 ] - Market Wire

Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011

[ Thu, Mar 24th 2011 ] - Market Wire

West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device

[ Thu, Mar 24th 2011 ] - Market Wire

Healthcare Acquisition Activity on the Rise as Key Patents Run Out

[ Thu, Mar 24th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Completes Patient E .. nical Trial Investigating REOLYSIN® in Combi

[ Thu, Mar 24th 2011 ] - Market Wire

Unigenea?s Oral Peptide Drug Delivery Technology .. ine Phase 3 Results from Tarsaa?s ORACAL Trial of

[ Thu, Mar 24th 2011 ] - Market Wire

Fase III klinische trial van Gileads onderzoeksge .. et aan primaire doelstelling voor eerste 48 weken

Wed, March 23, 2011

[ Wed, Mar 23rd 2011 ] - Market Wire

AdCare Health Systems Reports Record Fourth Quarter and Full Year 2010 Results

[ Wed, Mar 23rd 2011 ] - Market Wire

Affymax and Takeda to Present Additional Peginesa .. Patients at the National Kidney Foundation (NKF)

[ Wed, Mar 23rd 2011 ] - Market Wire

El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem

[ Wed, Mar 23rd 2011 ] - Market Wire

A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger

[ Wed, Mar 23rd 2011 ] - Market Wire

Mesa Uranium Files 43-101 Report, Expands the Green Energy Project

[ Wed, Mar 23rd 2011 ] - Market Wire

Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members

[ Wed, Mar 23rd 2011 ] - Market Wire

Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting

[ Wed, Mar 23rd 2011 ] - Market Wire

Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement

[ Wed, Mar 23rd 2011 ] - Market Wire

POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment

[ Wed, Mar 23rd 2011 ] - Market Wire

Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients

[ Wed, Mar 23rd 2011 ] - Market Wire

CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction

[ Wed, Mar 23rd 2011 ] - Market Wire

Announcement of the Execution of a License Agreement for Unoprostone

Tue, March 22, 2011

[ Tue, Mar 22nd 2011 ] - Market Wire

New Acetadote® Formulation Now Available in the U.S.

[ Tue, Mar 22nd 2011 ] - Market Wire

Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia

[ Tue, Mar 22nd 2011 ] - Market Wire

ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)

[ Tue, Mar 22nd 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup

[ Tue, Mar 22nd 2011 ] - Market Wire

LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO

[ Tue, Mar 22nd 2011 ] - Market Wire

Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex

[ Tue, Mar 22nd 2011 ] - Market Wire

POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation

[ Tue, Mar 22nd 2011 ] - Market Wire

Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia

[ Tue, Mar 22nd 2011 ] - Market Wire

Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia

[ Tue, Mar 22nd 2011 ] - Market Wire

Emergent BioSolutions to Present at Needham & Company Healthcare Conference

[ Tue, Mar 22nd 2011 ] - Market Wire

Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results

[ Tue, Mar 22nd 2011 ] - Market Wire

Given Imaging to Present at the 10th Annual Needham Healthcare Conference

Mon, March 21, 2011

[ Mon, Mar 21st 2011 ] - Market Wire

2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS

[ Mon, Mar 21st 2011 ] - Market Wire

U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum

[ Mon, Mar 21st 2011 ] - Market Wire

[ Mon, Mar 21st 2011 ] - Market Wire

Anacor Pharmaceuticals Secures $30 Million Loan Facility

[ Mon, Mar 21st 2011 ] - Market Wire

RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference

[ Mon, Mar 21st 2011 ] - Market Wire

Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA

[ Mon, Mar 21st 2011 ] - Market Wire

Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants

[ Mon, Mar 21st 2011 ] - Market Wire

Biotech Sector Is a Hotbed of Takeover Speculation

[ Mon, Mar 21st 2011 ] - Market Wire

Teleflex Announces Retirement of 2004 Senior Notes

[ Mon, Mar 21st 2011 ] - Market Wire

Given Imaging Wins Patent Infringement Lawsuit in Germany

[ Mon, Mar 21st 2011 ] - Market Wire

XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD

[ Mon, Mar 21st 2011 ] - Market Wire

Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting

Sun, March 20, 2011

[ Sun, Mar 20th 2011 ] - Market Wire

Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma

Fri, March 18, 2011

[ Fri, Mar 18th 2011 ] - Market Wire

Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data

[ Fri, Mar 18th 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag

[ Fri, Mar 18th 2011 ] - Market Wire

Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart

[ Fri, Mar 18th 2011 ] - Market Wire

Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2

[ Fri, Mar 18th 2011 ] - Market Wire

CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB

[ Fri, Mar 18th 2011 ] - Market Wire

Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes

[ Fri, Mar 18th 2011 ] - Market Wire

Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2

[ Fri, Mar 18th 2011 ] - Market Wire

Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products

[ Fri, Mar 18th 2011 ] - Market Wire

Affymax Announces Pricing of Public Offering of Common Stock

[ Fri, Mar 18th 2011 ] - Market Wire

Algoma Central Corporation Announces Increase to Bought Deal Financing

[ Fri, Mar 18th 2011 ] - Market Wire

Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science

[ Fri, Mar 18th 2011 ] - Market Wire

Declarao da Covidien sobre o impacto do terremoto japons

Thu, March 17, 2011

[ Thu, Mar 17th 2011 ] - Market Wire

Covidien Statement on the Impact of the Japanese Earthquake

[ Thu, Mar 17th 2011 ] - Market Wire

HearUSA Responds to Siemens Filing

[ Thu, Mar 17th 2011 ] - Market Wire

SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)

[ Thu, Mar 17th 2011 ] - Market Wire

CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal

[ Thu, Mar 17th 2011 ] - Market Wire

Antrim Energy Inc. Announces Closing of Financing

[ Thu, Mar 17th 2011 ] - Market Wire

Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit

[ Thu, Mar 17th 2011 ] - Market Wire

Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio

[ Thu, Mar 17th 2011 ] - Market Wire

ImmuCell Announces Sales and Marketing Collaboration With AgriLabs

[ Thu, Mar 17th 2011 ] - Market Wire

Prime Equity Research Initiates Independent Coverage On Fresh Start

[ Thu, Mar 17th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Announces 2010 Year End Results

[ Thu, Mar 17th 2011 ] - Market Wire

Alnylam Responds to Tekmira Complaint

[ Thu, Mar 17th 2011 ] - Market Wire

AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011

Wed, March 16, 2011

[ Wed, Mar 16th 2011 ] - Market Wire

El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien elige como presidente y director ejecutivo a Jose E. Almeida

[ Wed, Mar 16th 2011 ] - Market Wire

St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant

[ Wed, Mar 16th 2011 ] - Market Wire

PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER

[ Wed, Mar 16th 2011 ] - Market Wire

Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien Elects Jose E. Almeida President and Chief Executive Officer

[ Wed, Mar 16th 2011 ] - Market Wire

Covidien CEO to Retire July 1; Successor Named

[ Wed, Mar 16th 2011 ] - Market Wire

Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt

[ Wed, Mar 16th 2011 ] - Market Wire

CEO di Covidien in pensione dal 1 luglio - nominato successore

[ Wed, Mar 16th 2011 ] - Market Wire

TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES

[ Wed, Mar 16th 2011 ] - Market Wire

Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders

[ Wed, Mar 16th 2011 ] - Market Wire

AlphaRx Provides Corporate and Development Update

Tue, March 15, 2011

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting

[ Tue, Mar 15th 2011 ] - Market Wire

Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011

[ Tue, Mar 15th 2011 ] - Market Wire

Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock

[ Tue, Mar 15th 2011 ] - Market Wire

Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution

[ Tue, Mar 15th 2011 ] - Market Wire

Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration

[ Tue, Mar 15th 2011 ] - Market Wire

Biomagnetics Begins Miniaturization Process for Biosensor a" Major Step Toward Commercialization

[ Tue, Mar 15th 2011 ] - Market Wire

Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results

[ Tue, Mar 15th 2011 ] - Market Wire

Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women

[ Tue, Mar 15th 2011 ] - Market Wire

Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents

[ Tue, Mar 15th 2011 ] - Market Wire

Merck to Present at Barclays Capital 2011 Global Healthcare Conference

[ Tue, Mar 15th 2011 ] - Market Wire

Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results

[ Tue, Mar 15th 2011 ] - Market Wire

Illumina Prices $800 Million Convertible Senior Notes

Mon, March 14, 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study

[ Mon, Mar 14th 2011 ] - Market Wire

Teva to Present at the Barclays Capital 2011 Global Healthcare Conference

[ Mon, Mar 14th 2011 ] - Market Wire

Health Net, Inc. Investigating Unaccounted-for Server Drives

[ Mon, Mar 14th 2011 ] - Market Wire

Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging

[ Mon, Mar 14th 2011 ] - Market Wire

Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta

[ Mon, Mar 14th 2011 ] - Market Wire

HemaCare Reports Fourth Quarter and Year End Results

[ Mon, Mar 14th 2011 ] - Market Wire

Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve

[ Mon, Mar 14th 2011 ] - Market Wire

Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis

[ Mon, Mar 14th 2011 ] - Market Wire

Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging

[ Mon, Mar 14th 2011 ] - Market Wire

Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011

[ Mon, Mar 14th 2011 ] - Market Wire

Human Genome Sciences Appoints George Morrow to its Board of Directors

Sun, March 13, 2011

[ Sun, Mar 13th 2011 ] - Market Wire

DaVita Enhances Already Strong Governance Policies

Sat, March 12, 2011

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation

[ Sat, Mar 12th 2011 ] - Market Wire

Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation

Fri, March 11, 2011

[ Fri, Mar 11th 2011 ] - Market Wire

The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC

[ Fri, Mar 11th 2011 ] - Market Wire

Focus and SOQUEM confirm historical REE-Cu-Fe gra .. 52% TREO, 0.15% Cu, 3.70% P2O5 and 49.9% Fe2O3 at

[ Fri, Mar 11th 2011 ] - Market Wire

Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care

[ Fri, Mar 11th 2011 ] - Market Wire

Orthofix Sports Medicine Launches Three New Products in March

[ Fri, Mar 11th 2011 ] - Market Wire

Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference

[ Fri, Mar 11th 2011 ] - Market Wire

GTSO President to Participate in Rare Earths Briefing Today at U.S. Capitol

[ Fri, Mar 11th 2011 ] - Market Wire

Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab

[ Fri, Mar 11th 2011 ] - Market Wire

CytRx Reports 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Synta Announces Clinical Program Updates and 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????

[ Fri, Mar 11th 2011 ] - Market Wire

Centric Health Reports Solid 2010 Financial Results

[ Fri, Mar 11th 2011 ] - Market Wire

Covidien????????????????FDA??

Thu, March 10, 2011

[ Thu, Mar 10th 2011 ] - Market Wire

Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci

[ Thu, Mar 10th 2011 ] - Market Wire

A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation

[ Thu, Mar 10th 2011 ] - Market Wire

Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences y GlaxoSmithKline anuncian .. NLYSTA® (Belimumab) para el tratamiento del lupu

[ Thu, Mar 10th 2011 ] - Market Wire

Exenatide Once Monthly Showed Positive Results in Phase 2 Study

[ Thu, Mar 10th 2011 ] - Market Wire

CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth

[ Thu, Mar 10th 2011 ] - Market Wire

Northstar Healthcare Reports 2010 Results

[ Thu, Mar 10th 2011 ] - Market Wire

Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu

[ Thu, Mar 10th 2011 ] - Market Wire

Santarus Initiates Phase I Clinical Study with SAN-300

[ Thu, Mar 10th 2011 ] - Market Wire

BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering

[ Thu, Mar 10th 2011 ] - Market Wire

Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l

Wed, March 9, 2011

[ Wed, Mar 09th 2011 ] - Market Wire

Unigene to Present at the ROTH 23rd Annual OC Growth Stock Conference on March 15, 2011

[ Wed, Mar 09th 2011 ] - Market Wire

Exelixis Announces Pricing of $165.0 Million Public Offering of Common Stock

Parere positivo del Comitato per i prodotti medicinali per uso umano sul nuovo contraccettivo NOMAC-E2

_{//health-fitness.news-articles.net/content/2011/ .. uso-umano-sul-nuovo-contraccettivo-nomac-e2.html}
^{Published in Health and Fitness on Friday, March 18th 2011 at 12:20 GMT by Market Wire}

UTRECHT (Paesi Bassi) e WHITEHOUSE STATION (N.J., USA)--([ BUSINESS WIRE ])--Teva Pharmaceuticals Europe BV, sussidiaria di propriet di Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), e MSD (che opera come Merck negli Stati Uniti e in Canada) (NYSE:MRK) hanno oggi annunciato che il CHMP (Committee for Medicinal Products for Human Use) dell'Agenzia europea dei medicinali (EMA, European Medicines Agency) ha emesso parere positivo sul NOMAC-E2 (nomegestrolo acetato 2,5 mg/17-estradiolo 1,5 mg), una pillola contraccettiva orale combinata (COC) monofasica sperimentale che evita le gravidanze indesiderate. NOMAC-E2 associa 2 ormoni steroidei: il nomegestrolo acetato, una progestina altamente selettiva e derivata dal progesterone, e il 17 beta estradiolo (E2), un estrogeno simile a quello naturalmente presente nel corpo femminile.

Galleria Fotografica/Multimediale Disponibile: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6652101&lang=it ]

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire